Company Insights

ARE customer relationships

Explore interactive graphBrowse insights index
ARE customer relationship map

Alexandria Real Estate Equities (ARE): customer relationships that shape a life‑science landlord

Alexandria Real Estate Equities operates as a specialized REIT that develops, owns and leases Class A/A+ laboratory and office space to life‑science and technology tenants, monetizing primarily through long‑term rent and reimbursement streams and secondarily through development gains and joint‑venture dispositions. Its strategy is to create dense Megacampus ecosystems in leading U.S. innovation clusters, capture premium rents from large, creditworthy tenants, and retain high occupancy through infrastructure differentiation and renewal activity. For investors evaluating customer relationships, the key takeaways are concentration of blue‑chip tenants, long average lease tenors, and embedded upside from redevelopment and rent resets.
Visit https://nullexposure.com/ for primary research and relationship analytics.

Why tenants drive the valuation — one clear investment thesis

Alexandria’s value proposition is infrastructure plus tenancy: the company builds and operates mission‑critical lab facilities that command specialized rents and stickier occupancy profiles than generic office. The balance sheet and cashflow profile depend directly on tenant credit and lease duration — when top tenants expand or renew, valuation multiples expand because replacement cost and redevelopment pipelines are expensive and time‑consuming.

The specific customer relationship uncovered: a marquee Eli Lilly lease

Eli Lilly is leasing the 334,000‑square‑foot property at 15 Necco Street in Boston from Alexandria to house a new Institute for genetic medicine. This is an active, single‑tenant lease for a large, publicly traded pharmaceutical company and reinforces Alexandria’s strategy of securing investment‑grade, high‑profile life‑science occupants. According to a GEN Eng News report dated March 9, 2026, Lilly plans to base the Institute within that 12‑story building leased from Alexandria.

What each relationship means for cashflow and risk

The Lily/Lilly (LLY) lease is a prototypical Alexandria customer: large enterprise, long tenure, and high strategic importance. For investors that translates to predictable rental income, minimal near‑term volatility in occupancy for that asset, and limited free cashflow dilution from operating expense variability if the lease is structured as triple‑net.

All customer relationships in this review (complete coverage)

  • Eli Lilly — Alexandria will lease 15 Necco Street (334,000 sq ft) to Eli Lilly for a new Institute of genetic medicine; this is a high‑profile, large‑square‑foot, single‑occupant tenancy that aligns with Alexandria’s focus on marquee life‑science firms. According to GEN Eng News on March 9, 2026, Lilly plans to lease the building from Alexandria.

Company‑level constraints and what they signal about the operating model

Alexandria’s public disclosures and filings establish a coherent set of operating constraints that drive how customer relationships behave:

  • Contracting posture — long‑term, predictable leases. The weighted‑average remaining lease term is listed at 7.5 years overall and 9.7 years for the top 20 tenants, with many single‑tenant deals running 5–15 years and some ground‑lease purchase options extending decades. These contract tenors anchor cashflow duration and support borrowing capacity (company filing, December 31, 2025).

  • Counterparty profile — concentrated toward very large enterprises. Investment‑grade or publicly traded large‑cap tenants represented 53% of total annual rental revenue as of year‑end 2025, making Alexandria highly exposed to the credit and expansion decisions of a relatively small set of major tenants (company filing, December 31, 2025).

  • Criticality and sector focus — life science infrastructure is mission‑critical. Tenants include multinational pharma, biotech, academic research institutions and U.S. government research agencies; Alexandria provides specialized labs, energy and waste systems, and security features that are not readily substitutable, increasing tenant stickiness (company filing, December 31, 2025).

  • Lease economics — tenant pays a lot of the running costs. Approximately 92% of leases (by rental revenue) are triple‑net, shifting property expenses and many operating risks onto tenants and insulating Alexandria’s reported NOI from cost inflation (company disclosures).

  • Geographic concentration — North America, predominantly U.S. All properties are located within North America and concentrated in major clusters (Greater Boston, Bay Area, San Diego, Seattle, Research Triangle, etc.), which reduces regulatory diversity but increases exposure to local biotech cycles and regional capital markets (company filing).

  • Maturity and renewal dynamics — high renewal rates from incumbent base. Alexandria reports 82% of recent leasing activity came from existing tenants, indicating strong renewal economics and lower leasing cost relative to markets requiring high dealer‑of‑space churn (company filing).

  • Materiality and disposition posture — large tenants are material; asset sales are tactical. The prominence of large, investment‑grade tenants is explicitly material to revenue, while disposals of isolated assets are not presented as strategic shifts (company filing).

These constraints collectively describe a landlord that operates with high contract durability, concentration risk centered on large enterprise tenants, and operational insulation via triple‑net structures and mission‑critical infrastructure.

Visit https://nullexposure.com/ if you want the underlying filings and curated relationship sheets used to build this view.

Investment implications for operators and researchers

  • Upside drivers: Lease renewals and expansions by investment‑grade tenants preserve cashflow and support valuation multiple expansion; development pipelines in constrained innovation clusters are a competitive moat.
  • Key risks: Revenue concentration means that adverse strategic decisions by a handful of large tenants can move cashflow materially; regional biotech downturns increase vacancy and push concessions.
  • Operational considerations: The triple‑net structure and long WALE reduce expense volatility, but redevelopment and construction pipelines require capital discipline and successful pre‑leasing to avoid cashflow pressure.

Bottom line and next steps

Alexandria delivers a specialized landlord model that converts bespoke lab infrastructure into durable rental cashflow. The Eli Lilly lease at 15 Necco Street is a concrete example of the company’s strategy to lock in large, creditworthy life‑science tenants into long tenors inside differentiated assets. For investors and corporate operators evaluating customer counterparty risk and revenue durability, Alexandria’s disclosures signal high contract maturity, meaningful concentration, and operational criticality—a profile that supports premium pricing in buoyant markets and creates downside concentration in prolonged biotech soft patches.

For deeper relationship mapping and the primary documents behind these conclusions, visit https://nullexposure.com/ — access the research that links tenant actions to portfolio valuation.